Life AI Net
홈
아카이브
계산기
디렉토리
뉴스레터
로그인
한국어
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
홈
아카이브
계산기
디렉토리
뉴스레터
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
로그인
홈
아카이브
계산기
디렉토리
More
실시간
BioPharma Dive
Cytospire hauls in $83M for a new type of T cell engager
Samsung Biologics
Samsung Biologics Labor Talks Break Down, Gap Remains - thelec.net
Siemens Healthineers
CDC HoSt-TT certification for Siemens Healthineers total testosterone test expands patient access to gold standard equivalent results - News-Medical
Samsung Biologics
Samsung Biologics union continues first general strike, demands higher wages and performance-based pay - Korea JoongAng Daily
FierceBiotech
Private Swiss biotechs hit record funding amid slowdown in public financing
Samsung Biologics
Samsung Biologics' strike enters 5th day - Yonhap News Agency
eLife
Are kinocilia motile?
eLife
Human adherent cortical organoids in a multi-well format
Endpoints News
Vertex drops mRNA cystic fibrosis program over 'tolerability' issues
Bio-Rad
Bio-Rad Navigates Academic Headwinds and Geopolitical Shifts in Q1 2026 Financial Results - Lab Manager
FierceBiotech
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
BioPharma Dive
Cytospire hauls in $83M for a new type of T cell engager
Samsung Biologics
Samsung Biologics Labor Talks Break Down, Gap Remains - thelec.net
Siemens Healthineers
CDC HoSt-TT certification for Siemens Healthineers total testosterone test expands patient access to gold standard equivalent results - News-Medical
Samsung Biologics
Samsung Biologics union continues first general strike, demands higher wages and performance-based pay - Korea JoongAng Daily
FierceBiotech
Private Swiss biotechs hit record funding amid slowdown in public financing
Samsung Biologics
Samsung Biologics' strike enters 5th day - Yonhap News Agency
eLife
Are kinocilia motile?
eLife
Human adherent cortical organoids in a multi-well format
Endpoints News
Vertex drops mRNA cystic fibrosis program over 'tolerability' issues
Bio-Rad
Bio-Rad Navigates Academic Headwinds and Geopolitical Shifts in Q1 2026 Financial Results - Lab Manager
FierceBiotech
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
아카이브
이 기사는 아카이브에서 찾을 수 없습니다.